Sfoglia per Rivista
Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures
2010-01-01 Maroso, M; Balosso, S; Ravizza, T; Liu, J; Aronica, E; Iyer, Am; Rossetti, C; Molteni, M; Casalgrandi, M; Manfredi, ANGELO ANDREA M. A.; Bianchi, MARCO EMILIO; Vezzani, A.
Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses
2010-01-01 Villablanca, Ej; Raccosta, L; Zhou, D; Fontana, R; Maggioni, D; Negro, A; Sanvito, F; Ponzoni, M; Valentinis, B; Bregni, M; Prinetti, A; Steffensen, Kr; Sonnino, S; Gustafsson, Ja; Doglioni, C; Bordignon, C; Traversari, C; Russo, V
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy
2024-01-01 Levine, B. L.; Pasquini, M. C.; Connolly, J. E.; Porter, D. L.; Gustafson, M. P.; Boelens, J. J.; Horwitz, E. M.; Grupp, S. A.; Maus, M. V.; Locke, F. L.; Ciceri, F.; Ruggeri, A.; Snowden, J.; Heslop, H. E.; Mackall, C. L.; June, C. H.; Sureda, A. M.; Perales, M. -A.
VIRAL VECTORS FOR GENE THERAPY: THE ART OF TURNING INFECTIOUS AGENTS INTO VEHICLES OF THERAPEUTICS
2001-01-01 Kay, M. A.; Glorioso, J.; Naldini, Luigi
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures | 1-gen-2010 | Maroso, M; Balosso, S; Ravizza, T; Liu, J; Aronica, E; Iyer, Am; Rossetti, C; Molteni, M; Casalgrandi, M; Manfredi, ANGELO ANDREA M. A.; Bianchi, MARCO EMILIO; Vezzani, A. | |
Tumor-mediated liver X receptor-α activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses | 1-gen-2010 | Villablanca, Ej; Raccosta, L; Zhou, D; Fontana, R; Maggioni, D; Negro, A; Sanvito, F; Ponzoni, M; Valentinis, B; Bregni, M; Prinetti, A; Steffensen, Kr; Sonnino, S; Gustafsson, Ja; Doglioni, C; Bordignon, C; Traversari, C; Russo, V | |
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy | 1-gen-2024 | Levine, B. L.; Pasquini, M. C.; Connolly, J. E.; Porter, D. L.; Gustafson, M. P.; Boelens, J. J.; Horwitz, E. M.; Grupp, S. A.; Maus, M. V.; Locke, F. L.; Ciceri, F.; Ruggeri, A.; Snowden, J.; Heslop, H. E.; Mackall, C. L.; June, C. H.; Sureda, A. M.; Perales, M. -A. | |
VIRAL VECTORS FOR GENE THERAPY: THE ART OF TURNING INFECTIOUS AGENTS INTO VEHICLES OF THERAPEUTICS | 1-gen-2001 | Kay, M. A.; Glorioso, J.; Naldini, Luigi |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile